Organon & Co(us:OGN)
14.73
+0.20%
Updated on 2024-12-25
Open:14.68
Close:14.73
High:14.81
Low:14.51
Pre Close:14.70
Volume:1.14M
Amount:16.79M
Turnover:0.44%
Shares:257.54M
MarketCap:3.79B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 763 | 198140256 | 76.95% | 77 | 203 | 316 |
| 2024-03-31 | 765 | 197639292 | 77.25% | 81 | 223 | 317 |
| 2023-12-31 | 827 | 197818062 | 77.38% | 124 | 183 | 408 |
| 2023-09-30 | 753 | 196823054 | 77.00% | 67 | 229 | 317 |
| 2023-06-30 | 786 | 197136126 | 77.14% | 56 | 219 | 368 |
| 2023-03-31 | 833 | 195949690 | 77.01% | 63 | 235 | 379 |
| 2022-12-31 | 868 | 198691198 | 78.11% | 123 | 210 | 411 |
| 2022-09-30 | 877 | 192789326 | 75.79% | 71 | 238 | 414 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Blackrock Inc. | 32579067 | 12.65% | -951855 | -2.84% |
| 2024-06-30 | Vanguard Group Inc | 30213176 | 11.73% | -576674 | -1.87% |
| 2024-06-30 | Massachusetts Financial Services Co /Ma/ | 10090921 | 3.92% | -61926 | -0.61% |
| 2024-06-30 | State Street Corp | 9009276 | 3.50% | -286069 | -3.08% |
| 2024-06-30 | Nordea Investment Management Ab | 7430858 | 2.89% | 3460530 | 87.16% |
| 2024-06-30 | Lsv Asset Management | 6610768 | 2.57% | 2121940 | 47.27% |
| 2024-06-30 | Slate Path Capital Lp | 5393786 | 2.09% | 248000 | 4.82% |
| 2024-06-30 | Morgan Stanley | 5301779 | 2.06% | 262959 | 5.22% |
| 2024-06-30 | Sound Shore Management Inc /Ct/ | 4870683 | 1.89% | -154065 | -3.07% |
| 2024-06-30 | Geode Capital Management, Llc | 4165888 | 1.62% | 214484 | 5.43% |
About
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Address:30 Hudson Street,33rd floor
Website:http://www.organon.com
Market Movers